By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pronova BioPharma 

Vollsveien 6

Lysaker    1366  Norway
Phone: 47-22-534850 Fax: 47-22-534851


Company News
BASF Completes Acquisition of Pronova BioPharma 1/31/2013 11:02:32 AM
More than 97% of Pronova BioPharma's Shareholders Accept BASF's Offer for Pronova BioPharma 1/22/2013 10:31:33 AM
BASF Increases Cash Offer for Pronova BioPharma 1/15/2013 11:01:39 AM
Pronova BioPharma Gets $653.6 Million Takeover Bid From BASF 11/21/2012 7:34:30 AM
GlaxoSmithKline (GSK) Partner Pronova BioPharma Wins Lovaza Patent Case Against Teva Pharmaceutical Industries Limited (TEVA) & Par Pharmaceutical, Inc. 5/31/2012 7:38:43 AM
Pronova BioPharma: Q1 Results 5/10/2011 9:36:07 AM
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) and Pronova BioPharma Announce Top-line Results of the Pivotal Phase 3 Clinical Trial of TAK-085 in Japan for Treatment of Hypertriglyceridemia 5/10/2011 8:23:42 AM
GlaxoSmithKline (GSK) Partner Pronova BioPharma Settles Drug Case with Apotex Inc.; Apotex to Sell Generic Lovaza in U.S. from Q1 2015 3/30/2011 7:20:50 AM
Pronova BioPharma Strengthens Global Marketing and Increases Patent Protection 8/13/2010 8:32:44 AM
Pronova BioPharma Release: Strengthened Position Following Intellectual Property and Regulatory Approvals 5/11/2010 10:48:27 AM